- Home
- GP vs QNRX Comparison
GP vs QNRX Comparison
Compare GP & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GP | QNRX |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4M | 10.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | GP | QNRX |
|---|---|---|
| Price | $1.09 | $7.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 97.5K | 31.1K |
| Earning Date | 02-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,542,318.00 | N/A |
| Revenue This Year | $81.12 | N/A |
| Revenue Next Year | $91.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $5.01 |
| 52 Week High | $7.70 | $41.80 |
Technical Indicators
Market Signals| Indicator | GP | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 41.22 |
| Support Level | $0.89 | $7.13 |
| Resistance Level | $1.01 | $8.27 |
| Average True Range (ATR) | 0.08 | 0.78 |
| MACD | 0.00 | 0.19 |
| Stochastic Oscillator | 28.26 | 44.37 |
Price Performance
Historical ComparisonAbout GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.